Sánchez-Paulete, A. R., Cueto, F. J., Martínez-López, M., Labiano, S., Morales-Kastresana, A., Rodríguez-Ruiz, M. E., . . . Melero, I. (2016). Cancer Immunotherapy with Immunomodulatory Anti-CD137 and Anti-PD-1 Monoclonal Antibodies Requires BATF3-Dependent Dendritic Cells. American Association for Cancer Research (AACR).
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
Sánchez-Paulete, Alfonso R., et al. Cancer Immunotherapy with Immunomodulatory Anti-CD137 and Anti-PD-1 Monoclonal Antibodies Requires BATF3-Dependent Dendritic Cells. American Association for Cancer Research (AACR), 2016.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
Sánchez-Paulete, Alfonso R., et al. Cancer Immunotherapy with Immunomodulatory Anti-CD137 and Anti-PD-1 Monoclonal Antibodies Requires BATF3-Dependent Dendritic Cells. American Association for Cancer Research (AACR), 2016.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.